Serafilcon A toric contact lenses
DeviceSilicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)
Other names: LID226397
NCT Number: NCT05959200
The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Dr. Elsa Pao, OD, Oakland, California, United States
Subjects will be expected to attend 7 visits including a screening visit. The total duration of a subject's participation in the study will be approximately 40 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)
Other names: LID226397
Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)
Other names: ACUVUE® OASYS for ASTIGMATISM with HYDRACLEAR® PLUS, AOfAHP
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Other names: CLEAR CARE® Cleaning and Disinfecting Solution
Time frame: Day 1 Dispense, 10 minutes after lens insertion, for each wear period. Each wear period is approximately 14 days according to randomization assignment.
The investigator will view the contact lens through a slit lamp (biomicroscope) and record the axis orientation (-179° to +180°) as the number of degrees away from the ideal location (90° axis) either positive or negative depending on the direction (nasal [+] or temporal [-]). No hypothesis testing was prespecified for this endpoint.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03688672
Ametropia, Astigmatism
Columbus, Ohio, United States
View Trial DetailsNCT05483127
Ametropia, Astigmatism
Los Angeles, California, United States
View Trial DetailsNCT04632784
Ametropia, Eye Diseases
Busan, South Korea
View Trial DetailsNCT06165627
Ametropia, Astigmatism
Los Angeles, California, United States
View Trial Details